Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026

FITZ vs CTRE: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

CTRE Wins Head-to-Head Institutional Verdict (6–0 across 6 Pillars · 8–2 Matrix Metrics)

CTRE Overall Winner 6-Pillar Tally: FITZ 0 – 6 CTRE Matrix Metrics: FITZ 2 – 8 CTRE

As of Nov 16, 2026, CareTrust REIT, Inc (CTRE) is the stronger overall head-to-head candidate over FITZ (FITZ) in the Tradestie Institutional Equity Comparison Engine, winning 8–2 core matrix metrics and 6–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). FITZ carries a Unified Composite Score of 57.6/100 (HOLD) at $25.44 (N/M Forward P/E, N/A operating margin), whereas CTRE carries 55.4/100 (HOLD) at $37.39 (19.7x Forward P/E, 66.2% operating margin).

  • Composite vs. Pillar Nuance: While FITZ currently prints a higher short-term Unified Composite Score (57.6/100 HOLD vs. CTRE 55.4/100 HOLD), CTRE captures the overall institutional head-to-head verdict (8–2 matrix metrics and 6–0 across the 6 pillars) due to superior fundamental profitability (66.2% vs. N/A operating margin) and revenue trajectory (+33.2% vs. N/A YoY).

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About FITZ vs CTRE
FITZ US Equity
FITZ
Institutional Equity
$25.44
-2.15% 1D
Market Cap N/A
TTM Revenue N/A
Forward P/E N/M
Beta / 30D Vol 1.00β · 27% Vol
Unified Composite Score
57.6 / 100 HOLD
Tech 45.0 Fund 59.0 Flow 50.0 Mom 50.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 43
RSI-14: 43.0 · SMA20: $26.09 · SMA50: $25.92
CTRE NYSE Head-to-Head Winner
CareTrust REIT, Inc
Real Estate Investment Trusts
$37.39
-1.79% 1D
Market Cap $9.8B
TTM Revenue $615M
Forward P/E 19.7x
Beta / 30D Vol 0.15β · 28% Vol
Unified Composite Score
55.4 / 100 HOLD
Tech 42.0 Fund 48.0 Flow 57.0 Mom 50.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 52
RSI-14: 52.3 · SMA20: $37.15 · SMA50: $37.17

6-Pillar Scorecard Institutional Category Breakdown (FITZ 0 – 6 CTRE)

Columns: Metric · FITZ · CTRE
1. Valuation Multiples CTRE
Forward P/E N/M 19.7x
Trailing P/E N/M 23.9x
PEG Ratio N/M 1.26x
EV / Revenue N/M 18.5x
2. Growth & Scale CTRE
Revenue Growth (YoY) N/A +33.2%
Earnings Growth (YoY) N/A -0.8%
TTM Revenue (USD) N/A $615M
Market Cap N/A $9.8B
3. Profitability & Quality CTRE
Gross Margin N/A 95.7%
Operating Margin N/A 66.2%
Net Profit Margin N/A 59.2%
Return on Equity (ROE) N/A 7.7%
4. Balance Sheet & Cash Flow CTRE
Cash Generation (TTM) N/A $485M
Cash Flow Margin N/A 78.8%
Net Cash / Leverage N/A ROE $1.59B Net Debt (0.39x D/E)
Dividend Yield None (0.00%) 3.94%
5. Options & Positioning CTRE
Options Structure Phase UNCLASSIFIED CONSOLIDATION
Current IV / %ile N/A (N/A) 25.1% (11th %ile)
Put/Call OI Skew N/A 6.12x (Put-Skewed)
OBV Trend / Tech Phase NEUTRAL · Neutral DISTRIBUTION · Neutral
6. R&D & Supply-Chain Moat CTRE
OpEx & R&D Intensity N/A 29.5% of Rev ($182M)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning High-Margin Pricing Power Moat
Supply-Chain Role Institutional Equity Operator REIT - Healthcare Facilities Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: FITZ (2) vs CTRE (8)
Institutional Metric FITZ CTRE Criterion Row Edge
Market Capitalization
Scale
N/A $9.8B Larger Scale CTRE
Trailing P/E Ratio
Valuation
N/M 23.9x Lower Multiple CTRE
Forward P/E Ratio
Valuation
N/M 19.7x Lower Multiple CTRE
Revenue Growth (YoY)
Growth
N/A +33.2% Higher Growth CTRE
Operating Margin (TTM)
Profitability
N/A 66.2% Higher Margin CTRE
Net Profit Margin
Profitability
N/A 59.2% Higher Margin CTRE
Return on Equity (ROE)
Capital Efficiency
N/A 7.7% Higher ROE CTRE
52-Week Range Position
Momentum
16% ($23–$36) 30% ($35–$44) Stronger Trend CTRE
Beta / 30D Volatility
Risk Regime
1.00β · 27% Vol 0.15β · 28% Vol Lower Realized Risk FITZ
Unified Institutional Score
Composite Signal
57.6 / 100 (HOLD) 55.4 / 100 (HOLD) Higher Composite FITZ
Trailing 12M Revenue (USD)
Operating Scale
N/A $615M FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
N/A 95.7% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · N/M EV/Rev 1.26x PEG · 18.5x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
N/A (N/A ROE) $485M ($1.59B Net Debt (0.39x D/E)) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon CTRE +4.04 pp
FITZ: -1.74% · CTRE: +2.3%
3M Horizon FITZ +3.96 pp
FITZ: -0.9% · CTRE: -4.86%
6M Horizon FITZ +9.85 pp
FITZ: +0.51% · CTRE: -9.34%
1Y Horizon FITZ +9.85 pp
FITZ: +0.51% · CTRE: -9.34%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on FITZ vs CTRE. Trailing 12-month operating profitability (FITZ N/A vs CTRE 66.2%) and valuation multiples (FITZ N/M vs CTRE 19.7x Forward P/E) are benchmarked directly in Pillar 4 below.

FITZ ADR TTM Benchmark FX-Normalized USD
TTM RevenueN/A
Gross MarginN/A
Op. MarginN/A
ROE / Fwd P/EN/A · N/M
CTRE ADR TTM Benchmark FX-Normalized USD
TTM Revenue$615M
Gross Margin95.7%
Op. Margin66.2%
ROE / Fwd P/E7.7% · 19.7x

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
FITZ UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact FITZ Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
CTRE CONSOLIDATION
83d in phase · OBV DISTRIBUTION
Current IV 25.1%
IV Percentile 11th %ile
Put/Call OI Skew 6.12x (Put-Skewed)
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BULLISH
OBV Flow DISTRIBUTION
Exact CTRE Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
FITZ Moat Profile Cyclical / Execution-Driven Positioning
Institutional Equity Operator
Competes within the Institutional Equity value chain with N/A market capitalization and N/A operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published
CTRE Moat Profile High-Margin Pricing Power Moat
REIT - Healthcare Facilities Operator
Competes within the REIT - Healthcare Facilities value chain with $9.8B market capitalization and 66.2% operating margin.
OpEx & R&D Reinvestment 29.5% of Rev ($182M)
90D Engineering Disclosures 0 Published

Investor FAQ FITZ vs CTRE Key Questions & Quantitative Answers

As of Nov 16, 2026, CareTrust REIT, Inc (CTRE) is the stronger overall head-to-head candidate over FITZ (FITZ) in the Tradestie Institutional Equity Comparison Engine, winning 8–2 core matrix metrics and 6–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). FITZ carries a Unified Composite Score of 57.6/100 (HOLD) at $25.44 (N/M Forward P/E, N/A operating margin), whereas CTRE carries 55.4/100 (HOLD) at $37.39 (19.7x Forward P/E, 66.2% operating margin). Composite vs. Pillar Nuance: While FITZ currently prints a higher short-term Unified Composite Score (57.6/100 HOLD vs. CTRE 55.4/100 HOLD), CTRE captures the overall institutional head-to-head verdict (8–2 matrix metrics and 6–0 across the 6 pillars) due to superior fundamental profitability (66.2% vs. N/A operating margin) and revenue trajectory (+33.2% vs. N/A YoY).

CTRE leads the Growth & Scale pillar: FITZ posts N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin), compared with CTRE at +33.2% YoY revenue growth and -0.8% YoY earnings growth on $615M TTM revenue (95.7% gross margin, 66.2% operating margin). On trailing 12-month operating scale, FITZ generates N/A in USD-normalized revenue versus $615M for CTRE. In operating R&D and SG&A reinvestment, FITZ deploys N/A (0 90-day corporate R&D disclosures) versus 29.5% of Rev ($182M) (0 disclosures) for CTRE.

CTRE screens cheaper on headline valuation multiples. FITZ trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin), whereas CTRE trades at 19.7x Forward P/E, 23.9x Trailing P/E, 1.26x PEG, and 18.5x EV/Revenue (78.8% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against FITZ (N/A ROE) versus CTRE (7.7% ROE) capital efficiency.

In options market volatility and institutional positioning, FITZ carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (1.00β · 27% Vol realized risk). By comparison, CTRE carries 25.1% implied volatility (11th %ile, Compressed (<25th %ile)), a 6.12x (Put-Skewed) Put/Call open-interest ratio, DISTRIBUTION on-balance volume, and sits in a CONSOLIDATION options structure phase (0.15β · 28% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.